AFRICA

AP: As rich nations struggle, Africa’s virus response is praised (Anna, 9/22).

Thomson Reuters Foundation: Coronavirus rumors and regulations mar Burkina Faso’s malaria fight (Mednick, 9/21).

ASIA

Financial Times: India and Pakistan ramp up remdesivir production under Gilead deal (Findlay, 9/21).

Reuters: Philippines’ Duterte eases overseas travel ban on health workers (Lema/Morales, 9/21).

Washington Post: As infections ebb, Japan hopes it has cracked the covid code on coexisting with the virus (Denyer, 9/19).

EUROPE

AP: Poland seeks more flu vaccines amid shortage during pandemic (Gera, 9/22).

Reuters: Exclusive: E.U. in early talks with Italy’s ReiThera over potential vaccine supply deal — source (Parodi et al., 9/21).

Washington Post: Britain could face 50,000 coronavirus cases per day by mid-October, top government scientists warn (Adam, 9/21).

WIRED: Could a Century-Old TB Shot Protect Against Other Respiratory Diseases? (Vaidyanathan, 9/21).

LATIN AMERICA

The Guardian: Covid warnings ring out as Latin America bids to return to normality (Daniels et al., 9/19).

MIDDLE EAST

AP: Yemen gets new virus hospital after other facilities close (Olsen, 9/22).

NORTH AMERICA

Daily Beast: A Notorious COVID Troll Actually Works for Dr. Fauci’s Agency (Markay, 9/21).

New York Times: NIH Official Departs After Anonymous Posts Attacking Public Health Leaders (Montague, 9/21).

PRI: Atul Gawande: With right ‘political environment,’ U.S. can control the coronavirus (Hackel, 9/21).

STAT: Joe Biden’s campaign-trail challenge: Casting doubt on a Trump vaccine without fueling broader vaccine skepticism (Facher, 9/22).